Package 51991-380-06

{"route": ["ORAL"], "spl_id": "e7f5ef4d-6763-4908-9b64-c2a2f600b2c8", "openfda": {"nui": ["N0000175605", "N0000175076", "N0000182141", "N0000182137", "N0000175625", "N0000175624", "N0000175550"], "upc": ["0351991985068", "0351991379997", "0351991380061", "0351991379065", "0351991380993", "0351991381990", "0351991381068"], "unii": ["9HW64Q8G6G"], "rxcui": ["977427", "977434", "977438", "2056895"], "spl_set_id": ["c7bb6ba1-9a7f-43f5-b058-ef26d4b59221"], "pharm_class_pe": ["Decreased Immunologic Activity [PE]"], "pharm_class_epc": ["Kinase Inhibitor [EPC]", "mTOR Inhibitor Immunosuppressant [EPC]"], "pharm_class_moa": ["Protein Kinase Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "Cytochrome P450 2D6 Inhibitors [MoA]", "mTOR Inhibitors [MoA]"], "manufacturer_name": ["Breckenridge Pharmaceutical, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET in 1 BOTTLE (51991-380-06)", "package_ndc": "51991-380-06", "marketing_start_date": "20230313"}, {"sample": false, "description": "60 BLISTER PACK in 1 CARTON (51991-380-60)  / 10 TABLET in 1 BLISTER PACK (51991-380-99)", "package_ndc": "51991-380-60", "marketing_start_date": "20210521"}], "brand_name": "Everolimus", "product_id": "51991-380_e7f5ef4d-6763-4908-9b64-c2a2f600b2c8", "dosage_form": "TABLET", "pharm_class": ["Cytochrome P450 2D6 Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "Decreased Immunologic Activity [PE]", "Kinase Inhibitor [EPC]", "Protein Kinase Inhibitors [MoA]", "mTOR Inhibitor Immunosuppressant [EPC]", "mTOR Inhibitors [MoA]"], "product_ndc": "51991-380", "generic_name": "Everolimus tablets", "labeler_name": "Breckenridge Pharmaceutical, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Everolimus", "active_ingredients": [{"name": "EVEROLIMUS", "strength": ".5 mg/1"}], "application_number": "ANDA205432", "marketing_category": "ANDA", "marketing_start_date": "20210521", "listing_expiration_date": "20261231"}